Onconetix, Inc. — Director's Dealing 2023

Oct 11, 2023

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Blue Water Biotech, Inc. (BWV)
CIK: 0001782107
Period of Report: 2023-10-04

Reporting Person: CAMPBELL NEIL J (Director, Chief Executive Officer)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option	$0.4305	2033-10-04	Common Stock (532326)		Direct

Footnotes

F1: The option vests in quarterly increments over a period of three years from October 4, 2023, subject to Dr. Campbell's continued employment by the Company on the applicable vesting date.